We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
AXIS Capital
AXS
$7.27B
| $1.38M | ﹤0.01% |
25,675
+2,000
| +8% | +$109K |
|
1052
Essential Utilities
WTRG
$11.7B
| $1.38M | ﹤0.01% |
34,567
-699
| -2% | -$29.3K |
|
1053
Arrow Electronics
ARW
$10.8B
| $1.37M | ﹤0.01% |
9,578
-796
| -8% | -$99.1K |
|
1054
Nabors Industries
NBR
$1.3B
| $1.36M | ﹤0.01% |
14,654
-3,341
| -19% | -$340K |
|
1055
Liberty Energy
LBRT
$3.14B
| $1.36M | ﹤0.01% |
101,751
+17,884
| +21% | +$232K |
|
1056
Casey's General Stores
CASY
$21.8B
| $1.35M | ﹤0.01% |
5,551
-1,564
| -22% | -$355K |
|
1057
Toll Brothers
TOL
$12.2B
| $1.35M | ﹤0.01% |
17,059
+2,225
| +15% | +$149K |
|
1058
Crocs
CROX
$5.53B
| $1.35M | ﹤0.01% |
11,983
-8,695
| -42% | -$1.04M |
|
1059
Winnebago Industries
WGO
$767M
| $1.34M | ﹤0.01% |
20,124
+18,781
| +1,398% | +$1.12M |
|
1060
RenaissanceRe
RNR
$13.6B
| $1.34M | ﹤0.01% |
7,164
+694
| +11% | +$138K |
|
1061
i3 Verticals
IIIV
$265M
| $1.33M | ﹤0.01% |
58,168
+9,696
| +20% | +$226K |
|
1062
SLM Corp
SLM
$4.75B
| $1.33M | ﹤0.01% |
81,459
-1,629
| -2% | -$24.8K |
|
1063
Principal Financial Group
PFG
$25B
| $1.32M | ﹤0.01% |
17,470
+12,646
| +262% | +$912K |
|
1064
Fulton Financial
FULT
$4.48B
| $1.32M | ﹤0.01% |
111,043
-315,285
| -74% | -$3.8M |
|
1065
Autohome
ATHM
$2.46B
| $1.32M | ﹤0.01% |
45,270
-6,401
| -12% | -$191K |
|
1066
Myriad Genetics
MYGN
$369M
| $1.31M | ﹤0.01% |
56,543
-1,738
| -3% | -$37.9K |
|
1067
Simon Property Group
SPG
$65.7B
| $1.3M | ﹤0.01% |
11,283
+859
| +8% | +$93.6K |
|
|
PARA
1068
DELISTED
Paramount Global Class B
PARA
| $1.3M | ﹤0.01% |
81,682
-31,372
| -28% | -$567K |
|
|
UNVR
1069
DELISTED
Univar Solutions Inc.
UNVR
| $1.3M | ﹤0.01% |
36,141
+13,376
| +59% | +$475K |
|
1070
Life Time Group Holdings
LTH
$9.1B
| $1.28M | ﹤0.01% |
65,299
+20,986
| +47% | +$401K |
|
|
CPRX
1071
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.27M | ﹤0.01% |
94,744
+53,478
| +130% | +$770K |
|
1072
Jazz Pharmaceuticals
JAZZ
$15.8B
| $1.27M | ﹤0.01% |
10,255
+7
| +0.1% | +$942 |
|
|
LOGC
1073
DELISTED
ContextLogic
LOGC
| $1.27M | ﹤0.01% |
+193,117
| New | +$1.53M |
|
1074
Ambarella
AMBA
$2.77B
| $1.27M | ﹤0.01% |
15,166
-6,537
| -30% | -$478K |
|
1075
Monro
MNRO
$381M
| $1.26M | ﹤0.01% |
31,101
| – | – |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.